122 related articles for article (PubMed ID: 1531202)
1. Immunotherapy with paternal lymphocytes preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer.
Hasegawa I; Tani H; Takakuwa K; Yamada K; Kanazawa K; Tanaka K
Fertil Steril; 1992 Feb; 57(2):445-7. PubMed ID: 1531202
[TBL] [Abstract][Full Text] [Related]
2. Results of immunotherapy for patients with unexplained primary recurrent abortions--prospective non-randomized cohort study.
Nonaka T; Takakuwa K; Ooki I; Akashi M; Yokoo T; Kikuchi A; Tanaka K
Am J Reprod Immunol; 2007 Dec; 58(6):530-6. PubMed ID: 17997752
[TBL] [Abstract][Full Text] [Related]
3. Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion.
Khonina NA; Broitman EV; Shevela EY; Pasman NM; Chernykh ER
Arch Gynecol Obstet; 2013 Oct; 288(4):933-7. PubMed ID: 23558562
[TBL] [Abstract][Full Text] [Related]
4. Effect of paternal leukocyte immunization on implantation after biochemical pregnancies and repeated failure of embryo transfer.
Carp HJ; Toder V; Mashiach S; Rabinovici J
Am J Reprod Immunol; 1994; 31(2-3):112-5. PubMed ID: 8049020
[TBL] [Abstract][Full Text] [Related]
5. Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion.
Pandey MK; Agrawal S
Int Immunopharmacol; 2004 Feb; 4(2):289-98. PubMed ID: 14996420
[TBL] [Abstract][Full Text] [Related]
6. Immunological characteristics of nonpregnant women with unexplained recurrent spontaneous abortion who underwent paternal lymphocytes immunization.
Malinowski A; Wilczynski J; Zeman K; Glowacka E; Kolasa D; Szpakowski A; Oszukowski P; Szpakowski M
Zentralbl Gynakol; 1998; 120(10):493-502. PubMed ID: 9823650
[TBL] [Abstract][Full Text] [Related]
7. A practical approach to the prevention of miscarriage: part 2--active immunotherapy.
Check JH
Clin Exp Obstet Gynecol; 2010; 37(1):5-9. PubMed ID: 20420268
[TBL] [Abstract][Full Text] [Related]
8. [Immunization with partner lymphocytes: improvement of pregnancy rate in sterility patients].
Kuhn U; Campo R; Hinney B; Neumeyer H; Criel A; Gordts S; Kuhn W
Z Geburtshilfe Perinatol; 1993; 197(5):209-14. PubMed ID: 8273398
[TBL] [Abstract][Full Text] [Related]
9. [Efficiency of lymphocyte immunization by the partner in prevention of unexplained recurrent spontaneous abortion. II. Immunologic prognostic factors].
Malinowski A; Zeman K; Banasik M; Głowacka E; Wilczyński J; Pokoca L; Puchała B; Szpakowski M
Ginekol Pol; 1997 Apr; 68(4):173-80. PubMed ID: 9463081
[TBL] [Abstract][Full Text] [Related]
10. [Allogeneic leukocyte immunization combined with IVF-ET for treatment of infertility induced by recurrent spontaneous abortion].
Kong LH; Liu Z; Li H; Chen SM; Xing FQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1300-1. PubMed ID: 18676284
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of HLA antigens and immunotherapy for infertile couples who failed to conceive after in vitro fertilization-embryo tubal replacement (IVF-ETR)].
Matsuyama T; Kobayashi Y; Honda I; Inoue M; Fujii A
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1241-7. PubMed ID: 1431437
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of paternal lymphocyte immunotherapy and potential biomarker mixed lymphocyte reaction-blocking factor in an Argentinian cohort of women with unexplained recurrent spontaneous abortion and unexplained infertility.
Fainboim L; Belén S; González V; Fernández P
Am J Reprod Immunol; 2021 Aug; 86(2):e13422. PubMed ID: 33730440
[TBL] [Abstract][Full Text] [Related]
13. A new lymphocyte serotyping using cytotoxic antibodies from secondary recurrent aborters and its application in cases of recurrent abortion and infertility.
Hasegawa I; Tani H; Takakuwa K; Goto S; Yamada K; Kanazawa K
Fertil Steril; 1991 May; 55(5):906-10. PubMed ID: 2022268
[TBL] [Abstract][Full Text] [Related]
14. The outcome of in vitro fertilization in unexplained habitual aborters concurrent with secondary infertility.
Raziel A; Herman A; Strassburger D; Soffer Y; Bukovsky I; Ron-El R
Fertil Steril; 1997 Jan; 67(1):88-92. PubMed ID: 8986689
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid antibodies and human reproductive failure.
Balasch J; Creus M; Fábregues F; Reverter JC; Carmona F; Tàssies D; Font J; Vanrell JA
Hum Reprod; 1996 Oct; 11(10):2310-5. PubMed ID: 8943547
[TBL] [Abstract][Full Text] [Related]
16. Result of immunotherapy on patients with unexplained recurrent abortion: a beneficial treatment for patients with negative blocking antibodies.
Takakuwa K; Goto S; Hasegawa I; Ueda H; Kanazawa K; Takeuchi S; Tanaka K
Am J Reprod Immunol; 1990 Jun; 23(2):37-41. PubMed ID: 2145853
[TBL] [Abstract][Full Text] [Related]
17. Is an additional vaccination necessary for a successful second pregnancy in unexplained recurrent aborters who were successfully immunized with their husband's lymphocytes before the first pregnancy?
Takakuwa K; Higashino M; Yasuda M; Ishii S; Ueda H; Asano K; Kazama Y; Tanaka K
Am J Reprod Immunol; 1993 Jan; 29(1):39-44. PubMed ID: 8503994
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer.
Balasch J; Creus M; Fábregues F; Font J; Martorell J; Vanrell JA
Fertil Steril; 1996 Mar; 65(3):655-8. PubMed ID: 8774303
[TBL] [Abstract][Full Text] [Related]
19. Female third party lymphocytes are effective for immunotherapy of patients with unexplained primary recurrent spontaneous abortion: A retrospective analysis of outcomes.
Liang X; Qiu T; Qiu L; Wang X; Zhao A; Lin Q
Eur J Contracept Reprod Health Care; 2015; 20(6):428-37. PubMed ID: 25985825
[TBL] [Abstract][Full Text] [Related]
20. [Efficiency of paternal lymphocyte immunization in prevention of unexplained recurrent spontaneous abortion. I. Clinical prognostic factors].
Malinowski A; Szpakowski M; Wilczyński J; Oszukowski P; Woźniak P
Ginekol Pol; 1997 Apr; 68(4):165-72. PubMed ID: 9463080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
